|
⚲
|
| Keyboard |
| Atlas Venture Associates VII LP
✚
|
|
|---|---|
| CIK # | 0001377726, 0001377725 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001377725] | |
| 4 | [0001377725] | |
| 3 | [0001377726] | |
| 4 | [0001377726] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Atlas Venture Associates VII Inc | |
| Atlas Venture Associates VII LP | |
| Zafgen Inc | |
| Atlas Venture Fund VII L P | |
| Oruka Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Zafgen Inc ZFGN
Common Stock
|
2018-06-29 | Other | 1,126,546 | $0.00 | |
|
Zafgen Inc ZFGN
Common Stock
|
2018-06-29 | Other | 234,321 | $0.00 | |
|
Zafgen Inc ZFGN
Common Stock
|
2015-03-24 | Other | 1,000,000 | $0.00 | |
|
Zafgen Inc ZFGN
Common Stock
|
2014-06-24 | Conversion | 2,810,709 | ||
|
Zafgen Inc ZFGN
Common Stock
|
2014-06-24 | Conversion | 759,236 | ||
|
Zafgen Inc ZFGN
Series D Preferred Stock · derivative
|
2014-06-24 | Conversion | 4,690,696 | ||
|
Zafgen Inc ZFGN
Series A Preferred Stock · derivative
|
2014-06-24 | Conversion | 4,768,001 | ||
|
Zafgen Inc ZFGN
Series B Preferred Stock · derivative
|
2014-06-24 | Conversion | 17,651,253 | ||
|
Zafgen Inc ZFGN
Series C Preferred Stock · derivative
|
2014-06-24 | Conversion | 8,263,595 | ||
|
Zafgen Inc ZFGN
Common Stock
|
2014-06-24 | Conversion | 1,315,859 | ||
|
Zafgen Inc ZFGN
Common Stock
|
2014-06-24 | Conversion | 746,926 |